Mount Prospect, Illinois Clinical Trials

A listing of Mount Prospect, Illinois clinical trials actively recruiting patient volunteers.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Languages supported at study center
Age Group

Male only (2)
Female only (1)
Any (31)

Phase 0 (1)
Phase 1 (1)
Phase 2 (5)
Phase 3 (7)
Unknown (20)

Interventional (15)
Observational (7)

Eli Lilly and Company (4)
Cairo University (2)
Seagen Inc. (2)
Amgen (1)
AstraZeneca (1)
Celgene (1)
Delta University for Science and Technology (1)
Hacettepe University (1)
Hoag Memorial Hospital Presbyterian (1)
Kafrelsheikh University (1)
Mahidol University (1)
Papworth Hospital NHS Foundation Trust (1)
Poznan University of Medical Sciences (1)
Queen's University (1)
Sanofi (1)
TrialX (1)
University of Bern (1)
University of Jordan (1)
University of Split, School of Medicine (1)
pfizer (1)

No (27)
Yes (7)

Yes (25)
No (9)

English (2)
Arabic (1)
Armenian (1)
Australian English (1)
Hindi (1)
Spanish (1)

Adult (18+) (31)
Pediatric (Under 18) (19)

I am/have/had

I am/have/hadrecurrent endometrial cancer

I am/have/hadoptic neuritis

I am/have/hadmaintenance therapy

I am/have/hadheadache

I am/have/hadalzheimer's disease

I am/have/hadchronic progressive multiple sclerosis

I am/have/hadcardiovascular disease

I am/have/hadcarcinosarcoma

I am/have/hadmyelitis

I am/have/hadmarginal zone lymphoma

I am/have/hadhysterectomy

I am/have/hadpositron emission tomography

I am/have/hadgilbert's syndrome

I am/have/hadcarcinoma

I am/have/hadmini-mental state examination

I am/have/hadbone marrow plasma cells

I am/have/hadcancer therapy

I am/have/hadbody mass index

I am/have/hadhodgkin's disease

I am/have/hadcarboplatin paclitaxel

added new label for I am/have/had

I am looking for

I am looking forcyclophosphamide

I am looking forflortaucipir

I am looking forpaclitaxel

I am looking forVirtual trials

I am looking fordurvalumab

I am looking forAccepts healthy volunteers

I am looking forfludarabine

I am looking forOnline studies

I am looking foralkylating agents

I am looking forflorbetapir

I am looking fortirzepatide

I am looking forimmunomodulators

I am looking forimmunomodulator

I am looking forolaparib

I am looking foradjuvant

I am looking forcarboplatin

I am looking fordulaglutide

I am looking forplatinum-based chemotherapy

I am looking forcalcium

I am looking forimmunoglobulins

added new label for I am looking for

Advanced Filters

Found 33 clinical trials

Multi-country trial
Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

flortaucipir

florbetapir

positron emission tomography

alzheimer's disease

mini-mental state examination

AMITA Health - Alexian Brothers Neurosciences Institute Clinical Research

(4.4 away) Contact site

0 views
16 Feb, 2024
+85 other locations

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
all
Family Medicine
Recruiting

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

treatment regimen

preventive medication

migraine

ly573144

lasmiditan

Alexian Brothers Medical Center

(9.0 away) Contact site

0 views
16 Feb, 2024
+162 other locations

Multi-country trial
Phase 3
For adults
Recruiting in 1000s
Interventional Study
all
Family Medicine
Recruiting

Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 …

contraceptive use

multiple sclerosis

chronic progressive multiple sclerosis

secondary progressive multiple sclerosis

Investigational Site Number 8400011

(7.1 away) Contact site

0 views
12 Nov, 2020
+15 other locations